| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.67B | 5.57B | 5.89B | 8.62B | 8.74B | 7.51B |
| Gross Profit | 2.16B | 2.15B | 2.24B | 3.81B | 4.07B | 3.33B |
| EBITDA | 513.00M | 420.00M | 557.00M | 1.80B | 2.20B | 1.80B |
| Net Income | 359.00M | 463.00M | 427.00M | 1.51B | 2.25B | 1.72B |
Balance Sheet | ||||||
| Total Assets | 15.23B | 15.90B | 15.47B | 16.16B | 14.34B | 12.89B |
| Cash, Cash Equivalents and Short-Term Investments | 4.28B | 5.23B | 4.55B | 4.69B | 3.86B | 2.61B |
| Total Debt | 312.00M | 260.00M | 363.00M | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 1.44B | 1.69B | 1.31B | 1.68B | 1.43B | 1.59B |
| Stockholders Equity | 13.79B | 14.20B | 14.16B | 14.48B | 12.91B | 11.30B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.41B | 1.71B | 807.00M | 1.38B | -147.00M |
| Operating Cash Flow | 0.00 | 1.46B | 1.77B | 871.00M | 1.45B | -117.00M |
| Investing Cash Flow | 0.00 | -1.40B | -900.00M | 149.00M | -117.00M | -825.00M |
| Financing Cash Flow | 0.00 | -1.09B | -495.00M | -691.00M | -676.00M | -58.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥11.68B | 3.90 | ― | 1.23% | 49.34% | 151.38% | |
69 Neutral | ¥8.74B | 16.68 | ― | 3.26% | -35.91% | -76.18% | |
68 Neutral | ¥11.13B | 9.40 | ― | 3.70% | -3.86% | 26.92% | |
66 Neutral | ¥11.71B | 6.69 | 11.46% | 4.65% | 9.55% | 40.52% | |
65 Neutral | ¥12.90B | 27.31 | ― | 3.47% | -5.52% | 12.95% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | ¥7.21B | -31.41 | ― | 2.61% | -25.28% | -434.79% |